New Market Study, "QuantuMDx Group Limited - Product Pipeline Analysis, 2013 Update", Has Been Published
QuantuMDx Group Limited (QuantuMDx) is a medical device company. The company develops hand-held and portable low cost diagnostic, genomic sequencing and proteomic platforms capable of supporting the delivery of personalized medicine across both developed and developing nations. Its products include q-poc, q-seq and invenio devices. QuantuMDx devices are built using a range of complex technologies, such as nanowires, microfluidic technologies and also patent protected molecular biology technology. The company operates in the UK and the US. It has formed a...
View full press release